The Angioedema Quality of Life Questionnaire (AE-QoL) is a reliable and effective tool for measuring the impact of hereditary…
Articles by Margarida Maia, PhD
Children and young adults with angioedema rarely require airway management to ensure an open passage for airflow, but when…
Local cytokine release syndrome (L-CRS) is a potentially underrecognized complication of CAR T-cell therapy for blood cancer that can appear…
Injectable on-demand treatments for children with hereditary angioedema (HAE) are often associated with anxiety, pain, treatment delays, and high…
People with hereditary angioedema (HAE) who learn to accept and manage their disease, rather than constantly fighting or fearing…
Biocryst Pharmaceuticals is once again partnering with Neopharmed Gentili — now, with an Irish affiliate of the Italian pharmaceutical…
A single dose of lonvoguran ziclumeran (lonvo-z) left more than 60% of patients with hereditary angioedema (HAE) free…
Using a daily extended-release tablet of deucrictibant — an oral small molecule being developed by Pharvaris — together…
On-demand treatment with Ekterly (sebetralstat), marketed by Kalvista Pharmaceuticals for hereditary angioedema (HAE), reduced anxiety associated with…
Deucrictibant, an experimental oral small molecule from Pharvaris, delivers…